UPDATED Oct 02, 2022
Discover large cap Swiss Pharmaceuticals & Biotech companies that are on the SMI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ROGRoche Holding | CHF323.45 | 4.6% | -6.3% | CHF266.0b | CHF376.25 | PE18.1x | E7.3% | 2.9% | ||
| NOVNNovartis | CHF75.53 | 1.6% | -0.7% | CHF164.9b | CHF88.88 | PE7.3x | E4.2% | 4.0% | ||
| LONNLonza Group | CHF486.30 | 9.5% | -30.0% | CHF36.1b | CHF718.38 | PE39.7x | E16.9% | 0.6% | ||
| VIFNVifor Pharma | CHF178.85 | 1.9% | 48.9% | CHF11.6b | CHF153.50 | PE79.2x | E42.3% | 1.1% | ||
| BANBBachem Holding | CHF62.80 | 8.9% | -57.0% | CHF4.6b | CHF209.50 | PE47.2x | E16.4% | 1.1% | ||
| TECNTecan Group | CHF343.00 | 7.6% | -33.8% | CHF4.4b | CHF467.50 | PE41.7x | E17.6% | 0.8% | ||
| SFZNSiegfried Holding | CHF735.00 | 0.7% | -9.9% | CHF3.1b | CHF934.13 | PE24.2x | E10.6% | 0.4% | ||
| IDIAIdorsia | CHF12.86 | 1.5% | -41.6% | CHF2.3b | CHF22.91 | PS52x | E56.9% | n/a | ||
| SKANSKAN Group | CHF57.80 | 4.5% | 23.5% | CHF1.3b | CHF86.50 | PE193.3x | E38.8% | 0.4% | ||
| PPGNPolyPeptide Group | CHF29.00 | -4.3% | -75.8% | CHF955.2m | CHF46.60 | PE30.2x | E21.6% | 0.9% | ||
| COPNCosmo Pharmaceuticals | CHF46.15 | -2.6% | -41.9% | CHF756.1m | CHF86.52 | PE22.3x | E48.8% | 2.0% | ||
| BSLNBasilea Pharmaceutica | CHF39.90 | 3.1% | -7.8% | CHF472.5m | CHF73.98 | PE555.3x | E62.7% | 0% | ||
| MOLNMolecular Partners | CHF6.55 | 8.4% | -63.4% | CHF235.9m | CHF19.39 | PE2x | E-68.7% | n/a | ||
| XLSXlife Sciences | CHF32.40 | -6.6% | n/a | CHF171.2m | n/a | PE12.2x | n/a | n/a | ||
| RLFRelief Therapeutics Holding | CHF0.027 | 0.4% | -78.9% | CHF113.2m | n/a | PS17.3x | n/a | n/a | ||
| WBIOWockhardt Bio | CHF1.60 | 0% | -50.9% | CHF83.1m | n/a | PB0.3x | n/a | 0% | ||
| KURNKuros Biosciences | CHF1.55 | -11.4% | -34.3% | CHF56.6m | n/a | PS3.7x | n/a | n/a | ||
| SANNSanthera Pharmaceuticals Holding | CHF0.70 | -16.1% | -53.8% | CHF36.2m | CHF4.00 | PB27.3x | S90.5% | n/a | ||
| SPEXSpexis | CHF0.53 | -5.4% | n/a | CHF25.6m | n/a | PS46.4x | S67.2% | n/a | ||
| NWRNNewron Pharmaceuticals | CHF1.30 | -2.3% | -37.9% | CHF23.2m | CHF8.59 | PS4.1x | E66.5% | n/a | ||
| ADXNAddex Therapeutics | CHF0.14 | -1.4% | -90.0% | CHF7.1m | n/a | PS4.5x | E44.8% | n/a |